BioSpace News Archive

Business

Seismic Therapeutic Appoints Eric Larson as Senior Vice President of Finance and Heather Vital as Vice President of R&D Strategy

Seismic Therapeutic, Inc. today announced the appointment of Eric Larson as Senior Vice President of Finance and Heather Vital as Vice President of R&D Strategy.

April 13, 2022
·
4 min read
Business

LENZ Therapeutics and JIXING Announce an Exclusive Greater China License Agreement; RTW to Invest in LENZ Therapeutics

LENZ Therapeutics today announced that it has entered into an exclusive license agreement with Ji Xing Pharmaceuticals (JIXING) to develop and commercialize LNZ100 (aceclidine) and LNZ101 (aceclidine + brimonidine) for the treatment of presbyopia in Greater China.

April 13, 2022
·
4 min read
Biotech Beach

MitoQ Unveils Empowering New Branding That Champions Emerging Cell Health Category and Reflects Unique Science Leadership Position

MitoQ Ltd. today announced a complete transformation of the brand with a fresh new design, updated visual language and sustainable packaging.

April 13, 2022
·
5 min read
Drug Development

NeoImmuneTech Demonstrates NT-I7’s Broad Combination Potential with Immune Checkpoint Inhibitors and Immunocytokine at AACR 2022

Pre-clinical studies demonstrate NT-I7’s potential to enhance anti-tumor responses in combination with compounds targeting multiple biological pathways.

April 13, 2022
·
4 min read
Genetown

EdiGene Enters Research Collaboration With Peking University Cancer Hospital to Advance the Development of Targeted Therapy for Colorectal Cancer

EdiGene, Inc. said it has entered into a research collaboration with Peking University Cancer Hospital to understand gene mutation frequency and clinicopathologic features of patients with advanced colorectal cancer in China.

April 13, 2022
·
3 min read
Bio NC

9 Meters Biopharma Announces Allowance of Patent for Anti-GIP Monoclonal Antibody NM-136 for the Treatment of Serious Metabolic Conditions

9 Meters Biopharma, Inc. announced today that the Company has received notice from the United States Patent and Trademark Office (USPTO) that U.S. Patent Application No. 16/781,304 is allowed.

April 13, 2022
·
4 min read
Drug Development

Sonnet BioTherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of SON-1010 for Advanced Solid Tumors

Sonnet BioTherapeutics Holdings, Inc., announced today that dosing has been initiated in a Phase 1 clinical trial of SON-1010 (IL12-F H AB) in adult patients with advanced solid tumors.

April 13, 2022
·
5 min read
Business

Repligen to Report First Quarter 2022 Financial ResultsWebcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDT

Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2022 financial results on Wednesday, April 27, 2022.

April 13, 2022
·
2 min read
Genetown

iSpecimen Adds Acutis Diagnostics to Marketplace Platform to Support Oncology and Infectious Disease Research

iSpecimen Inc. today announced that it added Acutis Diagnostics (“Acutis”), a clinical diagnostics laboratory, to its platform as a laboratory services provider.

April 13, 2022
·
4 min read
Business

Theratechnologies Reports Financial Results for First Quarter Fiscal 2022 and Provides Business Update

Theratechnologies Inc. today reported business highlights and financial results for the first quarter of fiscal year 2022 ended February 28, 2022 (Q1 2022).

April 13, 2022
·
17 min read